The role of oxidative post-translational modifications in type 1 diabetes pathogenesis

被引:0
|
作者
Alhamar, Ghadeer [1 ]
Vinci, Chiara [2 ]
Franzese, Valentina [3 ,4 ,5 ]
Tramontana, Flavia [5 ]
Le Goux, Nelig [6 ]
Ludvigsson, Johnny [7 ]
Nissim, Ahuva [6 ]
Strollo, Rocky [3 ,4 ]
机构
[1] Dasman Diabet Inst, Dept Immunol & Microbiol, Dasman, Kuwait
[2] Univ Libre Bruxelles, Ctr Diabet Res, Brussels, Belgium
[3] San Raffaele Open Univ, Dept Promot Human Sci & Qual Life, Rome, Italy
[4] Fdn Policlin Univ Campus Biomed Roma, Dept Med, Rome, Italy
[5] Univ Campus Biomed Roma, Dept Med, Rome, Italy
[6] Queen Mary Univ London, William Harvey Res Inst, Biochem Pharmacol, London, England
[7] Linkoping Univ, Crown Princess Victor Childrens Hosp, Dept Biomed & Clin Sci, Div Pediat, Linkoping, Sweden
来源
FRONTIERS IN IMMUNOLOGY | 2025年 / 16卷
关键词
post-translational modifications; type; 1; diabetes; oxidative stress; neoepitopes; autoimmunity; insulin; autoantibodies; t cell; FREE AMINO-ACIDS; MODIFIED INSULIN; BETA-CELL; ANTIGENIC DETERMINANTS; PROTEIN CARBAMYLATION; BIOLOGICAL-ACTIVITY; MODIFIED GAD65; II COLLAGEN; T-CELLS; DAMAGE;
D O I
10.3389/fimmu.2025.1537405
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pathogenesis of type 1 diabetes (T1D) involves a complex interplay of genetic predisposition, immune processes, and environmental factors, leading to the selective destruction of pancreatic beta-cells by the immune system. Emerging evidence suggests that intrinsic beta-cell factors, including oxidative stress and post-translational modifications (PTM) of beta-cell antigens, may also contribute to their immunogenicity, shedding new light on the multifaceted pathogenesis of T1D. Over the past 30 years, neoepitopes generated by PTMs have been hypothesized to play a role in T1D pathogenesis, but their involvement has only been systematically investigated in recent years. In this review, we explored the interplay between oxidative PTMs, neoepitopes, and T1D, highlighting oxidative stress as a pivotal factor in immune system dysfunction, beta-cell vulnerability, and disease onset.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases
    Ryan, Brent J.
    Nissim, Ahuva
    Winyard, Paul G.
    REDOX BIOLOGY, 2014, 2 : 715 - 724
  • [2] Post-Translational Modifications and Diabetes
    Sharma, Chiranjeev
    Hamza, Abu
    Boyle, Emily
    Donu, Dickson
    Cen, Yana
    BIOMOLECULES, 2024, 14 (03)
  • [3] Investigation of post-translational modifications in type 2 diabetes
    Bhaswati Chatterjee
    Suman S. Thakur
    Clinical Proteomics, 2018, 15
  • [4] Investigation of post-translational modifications in type 2 diabetes
    Chatterjee, Bhaswati
    Thakur, Suman S.
    CLINICAL PROTEOMICS, 2018, 15
  • [5] Sirtuin Oxidative Post-translational Modifications
    Kalous, Kelsey S.
    Wynia-Smith, Sarah L.
    Smith, Brian C.
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [6] Oxidative post-translational modifications in histones
    Luis Garcia-Gimenez, Jose
    Roma-Mateo, Carlos
    Pallardo, Federico V.
    BIOFACTORS, 2019, 45 (05) : 641 - 650
  • [7] The role of post-translational modifications of huntingtin in the pathogenesis of Huntington's disease
    Wang, Yan
    Lin, Fang
    Qin, Zheng-Hong
    NEUROSCIENCE BULLETIN, 2010, 26 (02) : 153 - 162
  • [8] Detecting oxidative post-translational modifications in proteins
    Gianazza, E.
    Crawford, J.
    Miller, I.
    AMINO ACIDS, 2007, 33 (01) : 51 - 56
  • [9] Detecting oxidative post-translational modifications in proteins
    E. Gianazza
    J. Crawford
    I. Miller
    Amino Acids, 2007, 33 : 51 - 56
  • [10] Do post-translational beta cell protein modifications trigger type 1 diabetes?
    Storling, Joachim
    Overgaard, Anne Julie
    Brorsson, Caroline Anna
    Piva, Francesco
    Bang-Berthelsen, Claus Heiner
    Haase, Claus
    Nerup, Jorn
    Pociot, Flemming
    DIABETOLOGIA, 2013, 56 (11) : 2347 - 2354